AE	Adverse event
APRIL	A proliferation-inducing ligand
BCVA	Best-corrected visual acuity
BAFF	B-cell activating factor
CSCR	Central serous chorioretinopathy
CMV	Cytomegalovirus
FAF	Fundus autofluorescence
FA	Fluorescein angiography
HCQ	Hydroxychloroquine
IFNAR1	Interferon alpha/beta receptor subunit 1
IOP	Intraocular pressure
JAK	Janus kinase
MSC	Mesenchymal stromal cell
OCT	Optical coherence tomography
OCTA	Optical coherence tomography angiography
PSC	Posterior subcapsular cataract
RCT	Randomized controlled trial
RPE	Retinal pigment epithelium
SAE	Serious adverse event
SD-OCT	Spectral-domain optical coherence tomography
SLE	Systemic lupus erythematosus
SRI-4	SLE Responder Index 4
TYK2	Tyrosine kinase 2
URTI	Upper Respiratory Tract Infection
VTE	venous thromboembolis